DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,523,334 | +41.8% | 6,140 | +37.4% | 0.77% | +49.7% |
| Q2 2023 | $1,074,120 | -12.9% | 4,470 | -8.6% | 0.51% | -11.4% |
| Q1 2023 | $1,233,796 | -21.2% | 4,890 | -17.0% | 0.58% | -23.2% |
| Q4 2022 | $1,564,796 | +2.7% | 5,890 | 0.0% | 0.75% | -2.1% |
| Q3 2022 | $1,523,000 | +1.9% | 5,890 | 0.0% | 0.77% | +9.4% |
| Q2 2022 | $1,495,000 | -13.5% | 5,890 | 0.0% | 0.70% | +4.5% |
| Q1 2022 | $1,729,000 | +81.8% | 5,890 | +103.8% | 0.67% | +81.2% |
| Q4 2021 | $951,000 | +8.1% | 2,890 | 0.0% | 0.37% | -5.8% |
| Q3 2021 | $880,000 | +7.4% | 2,890 | -5.2% | 0.40% | +6.8% |
| Q2 2021 | $819,000 | +19.0% | 3,050 | 0.0% | 0.37% | +4.8% |
| Q1 2021 | $688,000 | +1.5% | 3,050 | 0.0% | 0.35% | -7.8% |
| Q4 2020 | $678,000 | +3.2% | 3,050 | 0.0% | 0.38% | -8.4% |
| Q3 2020 | $657,000 | +28.1% | 3,050 | +5.2% | 0.42% | +13.9% |
| Q2 2020 | $513,000 | +21.3% | 2,900 | -4.9% | 0.37% | +15.8% |
| Q1 2020 | $423,000 | -9.8% | 3,050 | 0.0% | 0.32% | +19.6% |
| Q4 2019 | $469,000 | +6.3% | 3,050 | 0.0% | 0.26% | -10.8% |
| Q3 2019 | $441,000 | +0.2% | 3,050 | 0.0% | 0.30% | -3.3% |
| Q2 2019 | $440,000 | -34.1% | 3,050 | -39.6% | 0.31% | -29.9% |
| Q1 2019 | $668,000 | +28.0% | 5,050 | 0.0% | 0.44% | +18.1% |
| Q4 2018 | $522,000 | -7.8% | 5,050 | -2.9% | 0.37% | +4.8% |
| Q3 2018 | $566,000 | +6.0% | 5,200 | -3.7% | 0.35% | -9.0% |
| Q2 2018 | $534,000 | -32.0% | 5,400 | -32.5% | 0.39% | -30.5% |
| Q1 2018 | $785,000 | – | 8,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |